петък, 18 май 2018 г.

FDA Approves Drug for Tough-to-Treat Migraines

Aimovig is the first of a new type of drug that aims to fight painful migraine headaches before they start.
Trouble viewing this email? View as a Webpage Friday, May 18, 2018
News Alert
Missing Images! Article
FDA Approves Drug for Tough-to-Treat Migraines
Aimovig is the first of a new type of drug that aims to fight painful migraine headaches before they start.
Video
How CGRP Treatment Works
Look inside the brain to see how this new class of drugs targets CGRP molecules, which are responsible for debilitating head pain.
Article
'Magnetic Pulse' Device May Prevent Migraines
People who used the hand-held device averaged 3 fewer migraines a month.
Article
The Healing Potential of Light
Bathing yourself in green light may stop migraines before they start. So how does it work?
Video
Migraine: A Day in the Life
See how a public school administrator deals with migraines every day.
Slideshow
What Makes a Migraine a Migraine?
More than 1 in 10 Americans, including 1 in 6 women, have migraines, but many have been misdiagnosed.
ADVERTISEMENT
 
ADVERTISEMENT

Няма коментари:

Публикуване на коментар